Table 5.
Study day | Time post dose (hrs) | |||
---|---|---|---|---|
Mean (% CV) azithromycin serum concentrations* | ||||
Cohort 1 | Cohort 2 | Cohorts 1 and 2 combined | ||
0 | 0 | 0 N = 52 | 0 N = 119 | 0 N = 171 |
2 | 0 | 216 (39) N = 49 | 195 (93) N = 114 | 201 (78) N = 163 |
2 | 3 | 1160 (44) N = 49 | 906 (58) N = 111 | 938 (54) N = 160 |
2 | 8 | 609 (48) N = 49 | 467 (59) N = 115 | 510 (56) N = 166 |
7 | NS | 44.7 (67) N = 48 | 26.9 (75) N = 118 | 320 (77) N = 166 |
Mean (% CV) chloroquine plasma concentrations* | ||||
0 | 0 | 0 N = 44 | 0 N = 107 | 0 N = 151 |
2 | 0 | 172 (35) N = 49 | 131 (53) N = 110 | 144 (48) N = 159 |
2 | 3 | 430 (36) N = 48 | 331 (44) N = 107 | 362 (43) N = 155 |
2 | 8 | 367 (43) N = 49 | 295 (40) N = 106 | 318 (43) N = 155 |
7 | NS | 54.5 (67) N = 49 | 35.1 (53) N = 112 | 41.0 (65) N = 166 |
Mean (% CV) desethylchloroquine plasma concentrations* | ||||
0 | 0 | 0 N = 43 | 0 N = 103 | 0 N = 146 |
2 | 0 | 95.1 (77) N = 49 | 77.5 (67) N = 110 | 82.9 (72) N = 159 |
2 | 3 | 170 (48) N = 49 | 138 (48) N = 107 | 148 (49) N = 156 |
2 | 8 | 160 (58) N = 49 | 147 (58) N = 104 | 151 (58) N = 153 |
7 | NS | 66.9 (94) N = 49 | 38.5 (87) N = 112 | 46.8 (97) N = 161 |
*Concentration is in ng/mL.
CV = coefficient of variation, NS = not specified.